Biopharmaceutical
Germany
Switzerland
Merck
Pipeline
Autoimmune
Expansion
M&A Advisory
Lazard
Full Credential Description
Chord Therapeutics. Switzerland, Germany. Announced Date 20/12/2021. Closed Date 31/01/2022. Merck Acquires Chord Therapeutics to Expand Neuroinflammatory Pipeline. Industry: Chord Therapeutics is a biopharmaceutical company focused on developing treatments for rare and severe autoimmune diseases.